ESTOSER Trademark

Trademark Overview

On Friday, December 16, 2011, a trademark application was filed for ESTOSER with the United States Patent and Trademark Office. The USPTO has given the ESTOSER trademark a serial number of 85497094. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 8, 2022. This trademark is owned by Glaxo Group Limited. The ESTOSER trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
estoser

General Information

Serial Number85497094
Word MarkESTOSER
Filing DateFriday, December 16, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 8, 2022
Registration Number4820379
Registration DateTuesday, September 29, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 22, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording ESTOSER has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Friday, April 8, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, September 29, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 29, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, August 26, 20151(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, July 17, 2015NOTICE OF ALLOWANCE CANCELLED
Thursday, July 23, 2015TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 10, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 9, 2014SOU EXTENSION 5 GRANTED
Tuesday, December 2, 2014SOU EXTENSION 5 FILED
Tuesday, December 2, 2014TEAS EXTENSION RECEIVED
Friday, June 27, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 26, 2014SOU EXTENSION 4 GRANTED
Monday, June 23, 2014SOU EXTENSION 4 FILED
Monday, June 23, 2014TEAS EXTENSION RECEIVED
Friday, January 17, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 16, 2014SOU EXTENSION 3 GRANTED
Thursday, January 9, 2014SOU EXTENSION 3 FILED
Thursday, January 9, 2014TEAS EXTENSION RECEIVED
Tuesday, August 6, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 5, 2013SOU EXTENSION 2 GRANTED
Friday, July 5, 2013SOU EXTENSION 2 FILED
Friday, August 2, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 5, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 14, 2012SOU EXTENSION 1 GRANTED
Friday, December 14, 2012SOU EXTENSION 1 FILED
Friday, December 14, 2012TEAS EXTENSION RECEIVED
Tuesday, July 17, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 22, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 22, 2012PUBLISHED FOR OPPOSITION
Wednesday, May 2, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 16, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 16, 2012ASSIGNED TO LIE
Monday, March 26, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 20, 2012ASSIGNED TO EXAMINER
Tuesday, December 27, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, December 20, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

estoser pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological